Form 4: Director Sells Planet Labs Stock Under 10b5-1 Plan

Planet Labs PBC Director Vijaya Gadde sold 20,000 shares of Class A Common Stock for approximately $26.77 per share under a pre-arranged trading plan.

Summary

• Vijaya Gadde, a Director of Planet Labs PBC, disposed of 20,000 shares of Class A Common Stock.
• The transaction occurred on January 22, 2026, at a weighted average price of $26.7675 per share.
• The shares were sold in multiple transactions at prices ranging from $26.76 to $26.815, inclusive.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction.
• Following this transaction, Gadde beneficially owns 250,169 shares directly.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a pre-scheduled insider sale under a 10b5-1 plan, which is a routine event for personal financial management and not typically indicative of company-specific news or performance.

Positives

• The sale was conducted under a Rule 10b5-1 plan, which suggests the transaction was pre-scheduled for personal financial management and not based on new, non-public information.

Negatives

• A director selling shares, even under a 10b5-1 plan, can sometimes be perceived by the market as a reduction in insider conviction, potentially leading to minor negative sentiment.

Risks

• Insider selling, even when pre-planned, can occasionally be misinterpreted by investors as a signal of a lack of confidence in the company's near-term prospects, which could impact market sentiment.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This is a routine insider transaction and does not directly relate to broader industry trends or competitive dynamics. Such sales are common for executives and directors for personal financial planning.

Stakeholder Impact

• Shareholders: May perceive the sale as a slight negative, though the impact is mitigated by the transaction being under a 10b5-1 plan, indicating it was pre-planned.

Key Dates

Recommendation

This Form 4 filing reports a routine, pre-scheduled sale of shares by a director under a 10b5-1 plan. Such transactions are typically for personal financial planning and do not usually signal a change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this filing. Investors should continue to hold and monitor company performance and broader market conditions.

Keywords

Planet Labs, PL, Vijaya Gadde, Insider Sale, Form 4, Stock Transaction, Director, 10b5-1 Plan, Class A Common Stock